Long-term theophylline treatment changes the effects of angiotensin II and adenosinergic agents on the seizure threshold

Brain Research Bulletin

Volumn 52, Issue 1, 2000, Pages 13-16

  Tchekalarova, Jana ^a   Kambourova, Tatjna ^a   Georgiev, Vasil ^a  

^a INSTITUTE OF PHYSIOLOGY   (Bulgaria)

Author keywords

Adenosinergic agents; Angiotensin II ergic agents; Mice; PTZ seizure threshold; Theophylline

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 6 N CYCLOPENTYLADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ANGIOTENSIN; LOSARTAN; LOSARTAN POTASSIUM; PENTETRAZOLE; SARMESIN; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SEIZURE; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD;

ADENOSINE; ANGIOTENSIN II; ANIMALS; CONVULSANTS; DIFFERENTIAL THRESHOLD; MALE; MICE; MICE, INBRED ICR; PENTYLENETETRAZOLE; RECEPTORS, PURINERGIC P1; SEIZURES; THEOPHYLLINE; TIME FACTORS;

EID: 0034192965     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(99)00254-3     Document Type: Article

References (35)

1. Allen A.M., Moeller I., Jenkins T.A., Zhuo J., Aldred G.P., Chai S.Y., Mendelsohn F.O. Angiotensin receptors in the nervous system. Brain Res. Bull. 47:1998;17-28.
2. Bohlen und Halbach O., Albrecht D. Opposite effects of angiotensin II and IV in the lateral nucleus of the amygdala. Brain Res. Bull. 47:1998;311-315.
3. 3H] adenosine release from in situ rat lung. J. Cardiovasc. Pharmacol. 16:1990;101-106.
4. 2a adenosine receptors Guanine nucleotide derivate regulation in porcine striatal membranes and digitonin soluble fraction . Neurochem. Int. 33:1998;121-129.
5. Dragunow M. Purinergic mechanism in epilepsy. Prog. Neurobiol. 31:1988;85-108.
6. Dunwiddie, T. V.; Fredholm, B. B. Adenosine neuromodulation. In: Jacobson, K. A.; Jarvis, M. F., eds. Purinergic approaches in experimental therapeutics. New York: Wiley-Liss, Inc.; 1997:328-359.
7. Dunwiddie T.V., Worth T. Sedative and anticonvulsant effects of adenosine analogs in mice and rats. J. Pharmac. Exp. Ther. 220:1982;70-76.
8. Fredholm B.B. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol. Toxicol. 76:1995;93-101.
9. Fredholm B.B., Jonson B., Lindgren E. Changes in noradrenaline release and in beta receptor number in rat hippocampus following long-term treatment with theophylline or L-phenylisopropyladenosine. Acta Physiol. Scand. 122:1984;55-60.
10. Georgiev V., Kambourova T. Angiotensin II effects on the threshold of chemical convulsion seizures. C. R. Acad. Bulg. Sci. 36:1983;1599-1602.
11. Georgiev V., Gyorgy L., Getova D., Markovska V. Some central effects of ANG II. Interaction with dopaminergic transmission. Acta Physiol. Pharmacol. Bulg. 11:1985;19-26.
12. Georgiev V., Johansson B., Fredholm B.B. Long-term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number. Brain Res. 612:1993;271-277.
13. Georgiev V., Lazarova M., Kambourova T. Interaction between angiotensin II, diazepam, clonazepam and di-n-propylacetatein in pentylenetetrazol kindling seizures in mice. Neuropeptides. 18:1991;187-191.
14. Georgiev V., Lazarova M., Kambourova T. Further evidence for the interaction between Angiotensin II and GABAergic transmission in pentylenetetrazol kindling seizures in mice. Neuropeptides. 28:1995;29-34.
15. Georgiev V., Tchekalarova J. Interaction of angiotensin II and adenosine receptors in pentylenetetrazol kindling seizures in mice. Brain Res. 779:1998;259-261.
16. Goldberg M.R., Curatolo P.W., Tung C., Robertson D. Caffeine down-regulates β-adrenoreceptors in rat forebrain. Neurosci. Lett. 31:1982;47-52.
17. Haley T., McCormick W. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15.
18. Holtzman S.G., Mante S., Minneman K.P. Role of adenosine receptors in caffeine tolerance. J. Pharmacol. Exp. Ther. 256:1991;62-68.
19. Jacobson, K. A.; von Lubitz, D. K.; Daly, J. W.; Fredholm, B. B. Adenosine receptor ligands: Differences with acute versus chronic treatment. Trends Pharmacol. Sci. 17:108-113; 1996.
20. Jarvis, M. F.; Williams, M. Adenosine in central nervous system function. In: Williams, M., ed. Adenosine and adenosine receptors. Totowa, NJ: Humana; 1990:423-463.
21. Johansson B., Georgiev V., Kuosmanen T., Fredholm B.B. Long-term treatment with some methylxanthines decreases the susceptibility to bicuculline- and pentylenetetrazol-induced seizures in mice. Relatioship to c-fos expression and receptor binding. Eur. J. Neurosci. 8:1996;2447-2458.
22. Lin Y., Phillis J.W. Chronic caffeine exposure reduces the excitant action of acetylcholine on cerebral cortical neurons. Brain Res. 524:1990;316-318.
23. Lin H.C., Wan F.J., Tung C., Tseng C.J. Adenosine and glutamate modulate the cardiovascular responses of ANG II and III in the area postrema of rats. J. Auton. Nerv. Syst. 51:1995;19-26.
24. Loscher W., Fiedler M. The role of technical biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Seasonal influences on maximal electroshock and pentylenetetrazol seizure thresholds. Epilepsy Res. 25:1996;3-10.
25. Lupica C.R., Berman R.F., Jarvis M.F. Chronic theophylline treatment increases adenosine A1 but not A2 receptor binding in the rat brain An autoradiographic study . Synapse. 9:1991;95-102.
26. Mally J., Connick J.H., Stone T.W. Theophylline down-regulates adenosine receptor function. Brain Res. 509:1990;141-144.
27. Murray T.F. Up-regulation of rat cortical adenosine receptors following chronic administration of theophylline. Eur. J. Pharmacol. 82:1982;113-114.
28. Murray T.F., Sanders R.C. Chronic theophylline exposure increases agonist and antagonist binding to A1 adenosine receptors in rat brain. Neuropharmacology. 27:1988;757-760.
29. Ohnishi A., Li P., Branch R.A., Biaggioni I.O., Jackson E.K. Adenosine in renin-dependent renovascular hypertension. Hypertension. 12:1988;152-161.
30. 1-adenosine receptors associated with reduced sensitivity to convulsants. Neuropharmacology. 26:1987;1173-1180.
31. Swinyard E.A., Boson F., Goodman L. Effects of epinephrine and norepinephrine on excitability of central nervous system of mice. J. Pharmacol. Exp. Therap. 13:1964;52-59.
32. Tchekalarova J., Georgiev V. Adenosine-angiotensin II interactions in pentylenetetrazol seizure threshold in mice. J. Physiol. (Paris). 93:1999;191-197.
33. Von Lubitz D.K., Paul I., Ji X., Carter M., Jacobson K.A. Chronic adenosine A1 receptor agonist and antagonist Effect on receptor density and N-methyl-D-aspartate induced seizures in mice . Eur. J. Pharmacol. 253:1994;95-99.
34. Zhang G., Franklin P.H., Murray T.F. Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility. J. Pharmacol. Exp. Ther. 264:1983;1415-1424.
35. Wright J.W., Harding J.W. Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci. Biobehav. Rev. 18:1994;21-53.